Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction.

Lindsey ML, Hall ME, Harmancey R, Ma Y.

Clin Proteomics. 2016 Sep 15;13:19. doi: 10.1186/s12014-016-9120-2. eCollection 2016. Review.

2.

Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.

Warmoes M, Lam SW, van der Groep P, Jaspers JE, Smolders YH, de Boer L, Pham TV, Piersma SR, Rottenberg S, Boven E, Jonkers J, van Diest PJ, Jimenez CR.

Oncotarget. 2016 Sep 27;7(39):63537-63548. doi: 10.18632/oncotarget.11535.

3.

Current state of the art for enhancing urine biomarker discovery.

Harpole M, Davis J, Espina V.

Expert Rev Proteomics. 2016 Jun;13(6):609-26. doi: 10.1080/14789450.2016.1190651.

PMID:
27232439
4.

Ion Mobility-Mass Spectrometry Analysis of Cross-Linked Intact Multiprotein Complexes: Enhanced Gas-Phase Stabilities and Altered Dissociation Pathways.

Samulak BM, Niu S, Andrews PC, Ruotolo BT.

Anal Chem. 2016 May 17;88(10):5290-8. doi: 10.1021/acs.analchem.6b00518. Epub 2016 May 2.

5.

Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.

Brücher BL, Li Y, Schnabel P, Daumer M, Wallace TJ, Kube R, Zilberstein B, Steele S, Voskuil JL, Jamall IS.

Clin Transl Med. 2016 Mar;5(1):13. doi: 10.1186/s40169-016-0093-6. Epub 2016 Apr 6. Review.

6.

Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.

Fu G, Du Y, Chu L, Zhang M.

Exp Biol Med (Maywood). 2016 Jun;241(11):1186-94. doi: 10.1177/1535370216629007. Epub 2016 Feb 3.

7.

The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Clement CC, Becerra A, Yin L, Zolla V, Huang L, Merlin S, Follenzi A, Shaffer SA, Stern LJ, Santambrogio L.

J Biol Chem. 2016 Mar 11;291(11):5576-95. doi: 10.1074/jbc.M115.655738. Epub 2016 Jan 6.

8.

A Dynamic Model of pH-Induced Protein G'e Higher Order Structure Changes derived from Mass Spectrometric Analyses.

Yefremova Y, Al-Majdoub M, Opuni KF, Koy C, Yan Y, Gross ML, Glocker MO.

Anal Chem. 2016 Jan 5;88(1):890-7. doi: 10.1021/acs.analchem.5b03536. Epub 2015 Dec 9.

9.

The potential clinical impact of the release of two drafts of the human proteome.

Ezkurdia I, Calvo E, Del Pozo A, Vázquez J, Valencia A, Tress ML.

Expert Rev Proteomics. 2015;12(6):579-93. doi: 10.1586/14789450.2015.1103186. Epub 2015 Oct 23.

10.

Molecular Cloning and Characterization of a (Lys)6-Tagged Sulfide-Reactive Hemoglobin I from Lucina pectinata.

Díaz-Ayala R, Moya-Rodríguez A, Pietri R, Cadilla CL, López-Garriga J.

Mol Biotechnol. 2015 Dec;57(11-12):1050-62.

11.

Exploring the potential of public proteomics data.

Vaudel M, Verheggen K, Csordas A, Raeder H, Berven FS, Martens L, Vizcaíno JA, Barsnes H.

Proteomics. 2016 Jan;16(2):214-25. doi: 10.1002/pmic.201500295. Epub 2015 Dec 15. Review.

12.

The 2012/2013 ABRF Proteomic Research Group Study: Assessing Longitudinal Intralaboratory Variability in Routine Peptide Liquid Chromatography Tandem Mass Spectrometry Analyses.

Bennett KL, Wang X, Bystrom CE, Chambers MC, Andacht TM, Dangott LJ, Elortza F, Leszyk J, Molina H, Moritz RL, Phinney BS, Thompson JW, Bunger MK, Tabb DL.

Mol Cell Proteomics. 2015 Dec;14(12):3299-309. doi: 10.1074/mcp.O115.051888. Epub 2015 Oct 4.

13.

Tools for visualization and analysis of molecular networks, pathways, and -omics data.

Villaveces JM, Koti P, Habermann BH.

Adv Appl Bioinform Chem. 2015 Jun 4;8:11-22. doi: 10.2147/AABC.S63534. eCollection 2015. Review.

14.

Profiling circulating microRNAs in maternal serum and plasma.

Ge Q, Shen Y, Tian F, Lu J, Bai Y, Lu Z.

Mol Med Rep. 2015 Sep;12(3):3323-30. doi: 10.3892/mmr.2015.3879. Epub 2015 Jun 3.

15.

OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.

Kraus VB, Blanco FJ, Englund M, Henrotin Y, Lohmander LS, Losina E, Önnerfjord P, Persiani S.

Osteoarthritis Cartilage. 2015 May;23(5):686-97. doi: 10.1016/j.joca.2015.03.002. Review.

16.

Two urinary peptides associated closely with type 2 diabetes mellitus.

Zhang M, Fu G, Lei T.

PLoS One. 2015 Apr 22;10(4):e0122950. doi: 10.1371/journal.pone.0122950. eCollection 2015.

17.

Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies.

Pedroza-Díaz J, Röthlisberger S.

Biochem Med (Zagreb). 2015;25(1):22-35. doi: 10.11613/BM.2015.003. Review.

18.

Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.

Harel M, Oren-Giladi P, Kaidar-Person O, Shaked Y, Geiger T.

Mol Cell Proteomics. 2015 Apr;14(4):1127-36. doi: 10.1074/mcp.M114.043364. Epub 2015 Jan 26.

19.

Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy.

Baird A, Lee J, Podvin S, Kurabi A, Dang X, Coimbra R, Costantini T, Bansal V, Eliceiri BP.

Gastrointest Cancer. 2014;2014(4):131-142.

20.

Lymph is not a plasma ultrafiltrate: a proteomic analysis of injured patients.

Dzieciatkowska M, D'Alessandro A, Moore EE, Wohlauer M, Banerjee A, Silliman CC, Hansen KC.

Shock. 2014 Dec;42(6):485-98. doi: 10.1097/SHK.0000000000000249.

Supplemental Content

Support Center